129
Views
0
CrossRef citations to date
0
Altmetric
General Medicine

Changes and Clinical Value of Serum miR-24 and miR-223 Levels in Patients with Severe Pneumonia

, , , , , & show all
Pages 3797-3804 | Received 23 Apr 2023, Accepted 16 Jul 2023, Published online: 28 Aug 2023

References

  • Guo K, Cai W, Chen Y, Shi Y, Xu Z, Chen C. Skeletal muscle depletion predicts death in severe community-acquired pneumonia patients entering ICU. Heart Lung. 2022;52:71–75. doi:10.1016/j.hrtlng.2021.11.013
  • Stafylaki D, Maraki S, Vaporidi K, et al. Impact of molecular syndromic diagnosis of severe pneumonia in the management of critically ill patients. Microbiol Spectr. 2022;10(5):e0161622. doi:10.1128/spectrum.01616-22
  • Eldaboosy S, Almoosa Z, Saad M, et al. Comparison between physiological scores SIPF, CURB-65, and APACHE II as predictors of prognosis and mortality in hospitalized patients with COVID-19 pneumonia: a multicenter study, Saudi Arabia. Infect Drug Resist. 2022;15:7619–7630. doi:10.2147/IDR.S395095
  • Wei Q, Chen X, Chen X, Yuan Z, Wang C. Contribution of IL-38 in lung immunity during pseudomonas aeruginosa-induced pneumonia. Shock. 2022;57(5):703–713. doi:10.1097/SHK.0000000000001919
  • Zhang F, Zhou Y, Ding J. The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges. Cell Mol Biol Lett. 2022;27(1):70. doi:10.1186/s11658-022-00368-y
  • Fernández-Pato A, Virseda-Berdices A, Resino S, et al. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg Microbes Infect. 2022;11(1):676–688. doi:10.1080/22221751.2022.2038021
  • Li J, Luu LDW, Wang X, et al. Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia. Emerg Microbes Infect. 2022;11(1):593–605. doi:10.1080/22221751.2022.2036582
  • Lin Y, Yang Y. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3. Pathol Res Pract. 2019;215(4):683–688. doi:10.1016/j.prp.2018.12.028
  • Houshmandfar S, Saeedi-Boroujeni A, Rashno M, Khodadadi A, Mahmoudian-Sani M-R. miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(11):2187–2195. doi:10.1007/s00210-021-02163-6
  • Losier A, Dela Cruz CS. New testing guidelines for community-acquired pneumonia. Curr Opin Infect Dis. 2022;35(2):128–132. doi:10.1097/QCO.0000000000000824
  • Muhammad W, Zhai Z, Wang S, Gao C. Inflammation-modulating nanoparticles for pneumonia therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14(2):e1763. doi:10.1002/wnan.1763
  • Rathbun KP, Bourgault AM, Sole ML. Oral microbes in hospital-acquired pneumonia: practice and research implications. Crit Care Nurse. 2022;42(3):47–54. doi:10.4037/ccn2022672
  • Dadhwal K, Stonham R, Breen H, Poole S, Saeed K, Dushianthan A. Severe COVID-19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses. Clin Respir J. 2022;16(4):301–308. doi:10.1111/crj.13482
  • Li S, Zhang J, Feng G, et al. The emerging role of extracellular vesicles from mesenchymal stem cells and macrophages in pulmonary fibrosis: insights into miRNA delivery. Pharmaceuticals. 2022;15(10):1276. doi:10.3390/ph15101276
  • Fan X, Zou X, Liu C, et al. Identify miRNA-mRNA regulation pairs to explore potential pathogenesis of lung adenocarcinoma. Aging. 2022;14(20):8357–8373. doi:10.18632/aging.204341
  • Qin L, Zhong M, Adah D, et al. A novel tumour suppressor lncRNA F630028O10Rik inhibits lung cancer angiogenesis by regulating miR-223-3p. J Cell Mol Med. 2020;24(6):3549–3559. doi:10.1111/jcmm.15044
  • Nouws J, Wan F, Finnemore E, et al. MicroRNA miR-24-3p reduces DNA damage responses, apoptosis, and susceptibility to chronic obstructive pulmonary disease. JCI Insight. 2021;6(2). doi:10.1172/jci.insight.134218
  • Ren J, Guo W, Feng K, Huang T, Cai Y. Identifying MicroRNA markers that predict COVID-19 severity using machine learning methods. Life. 2022;12(12). doi:10.3390/life12121964
  • Li K, Wu J, Wu F, et al. The clinical and chest CT features associated with severe and critical COVID-19 pneumonia. Invest Radiol. 2020;55(6):327–331. doi:10.1097/RLI.0000000000000672
  • Roffel MP, Maes T, Brandsma C-A, et al. MiR-223 is increased in lungs of patients with COPD and modulates cigarette smoke-induced pulmonary inflammation. Am J Physiol Lung Cell Mol Physiol. 2021;321(6):L1091–L1094. doi:10.1152/ajplung.00252.2021
  • Zhang D, Lee H, Wang X, et al. A potential role of microvesicle-containing miR-223/142 in lung inflammation. Thorax. 2019;74(9):865–874. doi:10.1136/thoraxjnl-2018-212994